tiprankstipranks
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
US Market

RAPT Therapeutics (RAPT) Technical Analysis

Compare
360 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
RAPT Therapeutics’s (RAPT) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting RAPT Therapeutics is a Buy.
RAPT Therapeutics’s (RAPT) 20-Day exponential moving average is 1.16, while RAPT Therapeutics’s (RAPT) share price is $1.12, making it a Sell.
RAPT Therapeutics’s (RAPT) 50-Day exponential moving average is 1.24, while RAPT Therapeutics’s (RAPT) share price is $1.12, making it a Sell.

RAPT Therapeutics (RAPT) Pivot Points

Mar 08, 2025, 11:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.03
1.06
1.09
1.12
1.15
1.18
1.21
Fibonacci
1.06
1.08
1.10
1.12
1.14
1.16
1.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RAPT Therapeutics (RAPT) Moving Averages

Mar 08, 2025, 11:58 AM
Period
Simple
Exponential
MA5
1.11Buy
1.12Buy
MA10
1.14Sell
1.13Sell
MA20
1.16Sell
1.16Sell
MA50
1.27Sell
1.24Sell
MA100
1.40Sell
1.57Sell
MA200
2.12Sell
2.76Sell
RAPT Therapeutics’s (RAPT) 10-Day exponential moving average is 1.13, while RAPT Therapeutics’s (RAPT) share price is $1.12, making it a Sell.
RAPT Therapeutics’s (RAPT) 100-Day exponential moving average is 1.57, while RAPT Therapeutics’s (RAPT) share price is $1.12, making it a Sell.
RAPT Therapeutics’s (RAPT) stock price is $1.12 and RAPT Therapeutics’s (RAPT) 50-day simple moving average is 1.27, creating a Sell signal.
RAPT Therapeutics’s (RAPT) stock price is $1.12 and RAPT Therapeutics’s (RAPT) 100-day simple moving average is 1.40, creating a Sell signal.
RAPT Therapeutics’s (RAPT) stock price is $1.12 and RAPT Therapeutics’s (RAPT) 200-day simple moving average is 2.12, creating a Sell signal.

RAPT Therapeutics (RAPT) Technical Indicators

Mar 08, 2025, 11:58 AM
Name
Value
Implied Action
RSI (14)
45.07
Neutral
STOCH (9,6)
33.93
Neutral
STOCHRSI (14)
32.22
Neutral
MACD (12,26)
-0.03
Buy
ADX (14)
14.14
Buy
Williams %R
-66.67
Buy
CCI (14)
-48.47
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
44.21
Neutral
ROC
-5.88
Sell
RAPT Therapeutics’s (RAPT) Relative Strength Index (RSI) is 45.07, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Trend Strength Indicator (ADX) is 14.14, creating a Buy signal.
RAPT Therapeutics’s (RAPT) Commodity Channel Index (CCI) is -48.47, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Price Rate of Change (ROC) is -5.88, creating a Sell signal.

FAQ

Is RAPT a Buy, Hold, or Sell?
Based on RAPT’s technical indicators, RAPT is a Sell.
    What is RAPT’s RSI (14)?
    RAPT’s RSI (14) is 45.07, which suggests RAPT is a Neutral.
      What is RAPT’s MACD?
      RAPT’s MACD is -0.03, which suggests RAPT is a Buy.
        What is RAPT’s 5-day moving average?
        RAPT’s 5-day moving average is 1.11, which suggests RAPT is a Buy.
          What is RAPT’s 20-day moving average?
          RAPT 20-day moving average is 1.16, which suggests RAPT is a Sell.
            What is RAPT’s 50-day moving average?
            RAPT’s 50-day moving average is 1.27, which suggests RAPT is a Sell.
              What is RAPT’s 200-day moving average?
              RAPT’s 200-day moving average is 2.12, which suggests RAPT is a Sell.
                What is RAPT’s Williams % R (14)?
                RAPT’s Williams % R (14) is -66.67, which suggests RAPT is a Buy.
                  What is RAPT’s CCI (14)?
                  RAPT’s CCI (14) is -48.47, which suggests RAPT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis